SYNGR3 was also identified as being downregulated in a subgroup of HNSCC with high beta-adrenergic signaling, which was also associated with HPV negativity (138), and a known indicator of worse prognosis (139). Here, SYNGR3 is linked to head and neck squamous cell carcinoma.